XTANDI TODAY.
A CHANCE TO LIVE LONGER.

For prostate cancer that has spread to other parts of the body and responds to a hormone therapy or surgical treatment that lowers testosterone, XTANDI + ADT reduced the risk of death by 34% compared with men on ADT alone.

At the time of analysis, there were 154 out of 574 (27%) deaths in the XTANDI group, compared with 202 out of 576 (35%) deaths in the ADT-alone group.


View study data for this and other approved uses

View study data
Patient with family member

Real patients. Real XTANDI Xperiences.

Gain perspectives into the lives of men living with prostate cancer and their family.

XTANDI may cause serious side effects: seizure, a brain condition called PRES, allergic reactions, heart disease that can lead to death, falls and bone fractures, swallowing problems or choking that can lead to death. Learn more

Black Men on Facing Prostate Cancer

Man to man: Watch a conversation about prostate cancer in the Black community.

Watch this story
Black Men on Facing Prostate Cancer

Euvon, advocate for Black men's health and XTANDI patient

DOCTOR DISCUSSION GUIDE

Bring this guide to your next doctor's appointment

Take charge of your care. This guide is full of questions to ask your doctor about prostate cancer and XTANDI.

Get the guide
Icon: Prostate cancer patient discussing XTANDI® with his doctor
Sign up for support emails and resources

Sign up for
support

We’re here for you with tools, tips, helpful information, and resources.

Sign up

For more information on Financial Support, please call 1-855-898-2634